Section of General Internal Medicine, Women's Health Unit, Boston University School of Medicine, Boston, MA, USA.
Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA.
Med Decis Making. 2019 Apr;39(3):217-227. doi: 10.1177/0272989X19827258. Epub 2019 Feb 25.
Literature on decision making about breast cancer prevention focuses on individual perceptions and attitudes that predict chemoprevention use, rather than the process by which women decide whether to take risk-reducing medications. This secondary analysis aimed to understand how women's perceptions of breast cancer risk and locus of control influence their decision making.
Women were accrued as part of the NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project 1, a study aimed at understanding contributors to chemoprevention uptake. Thirty women participated in qualitative in-depth interviews after being counseled about chemoprevention. Deductive codes grouped women based on dimensions of risk perception and locus of control. We used a constant comparative method to make connections among inductive themes focused on decision making, deductive codes for perceived risk and perceived locus of control, and the influence of explanatory models within and across participants.
Participants were predominantly non-Hispanic white (63%), with an average age of 50.9 years. Decision making varied across groups: the high-perceived risk/high-perceived control group used "social evidence" to model the behaviors of others. High-perceived risk/low-perceived control women made decisions based on beliefs about treatment, rooted in the experiences of social contacts. The low-perceived risk/low-perceived control group interpreted signs of risk as part of the normal continuum of bodily changes in comparison to others. Low-perceived risk/high-perceived control women focused on maintaining a current healthy trajectory.
"Social evidence" plays an important role in the decision-making process that is distinct from emotional aspects. Attending to patients' perceptions of risk and control in conjunction with social context is key to caring for patients at high risk in a way that is evidence based and sensitive to patient preferences.
有关乳腺癌预防决策的文献主要关注预测化学预防使用的个体认知和态度,而不是女性决定是否服用降低风险药物的决策过程。本二次分析旨在了解女性对乳腺癌风险的感知和控制源如何影响她们的决策。
NRG 肿瘤学/国家外科辅助乳腺和肠道项目决策项目 1 部分纳入了这些女性,该研究旨在了解化学预防药物使用的促成因素。在接受化学预防咨询后,30 名女性参加了定性深入访谈。演绎代码根据风险感知和控制源的维度对女性进行分组。我们使用恒比比较法,在关注决策的归纳主题、感知风险和感知控制源的演绎代码,以及解释模型在参与者内部和之间的影响之间建立联系。
参与者主要是非西班牙裔白人(63%),平均年龄为 50.9 岁。决策因组而异:高感知风险/高感知控制组使用“社会证据”来模拟他人的行为。高感知风险/低感知控制女性根据对治疗的信念做出决策,这些信念根植于社会接触者的经验。低感知风险/低感知控制组将风险迹象解释为与他人相比身体变化的正常连续体的一部分。低感知风险/高感知控制女性则关注保持当前健康轨迹。
“社会证据”在决策过程中起着重要作用,与情绪方面不同。关注患者对风险和控制的感知以及社会背景是为高风险患者提供基于证据且敏感患者偏好的护理的关键。